Pharma & Biotech News #PharmaBuzz

FAMAR CDMO- From early development to commercial manufacturing.

Weekly News Recap #Phispers

FDA issues warning letter to Chinese supplier of semaglutide; approves AstraZeneca's new treatment for hypertension

In Phispers this week, the US Food and Drug Administration (FDA) approved AstraZeneca’s first-in-class treatment for hype...

Impressions : 1327

FDA chief Marty Makary resigns after rocky tenure; Italy's Angelini to buy Catalyst Pharma for US$ 4.1 billion

The US Food and Drug Administration (FDA) has seen several high profile exits under the Trump Administration. The most high pro...

Impressions : 1460

FDA issues warning letter to Intas' plant in north India; okays Axsome's drug for Alzheimer's-related agitation

In Phispers this week, India’s Intas Pharmaceuticals received a warning letter from the US Food and Drug Administration (...

Impressions : 1877

India's Sun Pharma acquires Organon for about US$ 11.75 bn; Lilly to buy Ajax Therapeutics for up to US$ 2.3 bn

In Phispers this week, Indian drugmaker Sun Pharmaceutical acquired Jersey-based Organon in an all-cash deal valued at about US...

Impressions : 1760

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

FDA issues warning letter to Chinese supplier of semaglutide; approves AstraZeneca's new treatment for hypertension

FDA chief Marty Makary resigns after rocky tenure; Italy's Angelini to buy Catalyst Pharma for US$ 4.1 billion

FDA issues warning letter to Intas' plant in north India; okays Axsome's drug for Alzheimer's-related agitation

India's Sun Pharma acquires Organon for about US$ 11.75 bn; Lilly to buy Ajax Therapeutics for up to US$ 2.3 bn

Actavis's Generics Linaclotide Receives Tentative Approval in US

Aspiro's Generics Isoproterenol HCl Receives Approval in US

Quagen's Generics Glycopyrrolate Receives Approval in US

Jubilant Generics' Generics Tadalafil Receives Approval in US

Ascent's Generics Clomiphene Citrate Receives Approval in US

Zydus' Generics Ammonium Lactate Receives Approval in US

Dr Reddy's Generics Phytonadione Receives Approval in US

Dr Reddy's Generics Venetoclax Receives Approval in US

Astrazeneca Pharms' Baxfendy Receives Approval in US

Ionetix's Generics Gallium Gozetotide Receives Approval in US

Hangzhou Yiqi Biotechnology's Receives FDA Warning Letter

Naseem A Jaffrani's Receives FDA Warning Letter

Sourav K Mishra's Receives FDA Warning Letter

JW Nutritional's Receives FDA Warning Letter

Best Supplements Recalls WAP Capsules for Undeclared Active Drugs

Sun Pharma Recalls Doxorubicin Injection Over Glass Particle Risk

Pharmacal Issues Nationwide Recall of MG217 Eczema Cream

Mukesh B Chandre's Receives FDA Warning Letter

IDO Pharma's Receives FDA Warning Letter

ProRx's Receives FDA Warning Letter

Parabilis IPO Follows Regeneron Deal Amid Rising IPO Listings

India Plans National Registry to Track Devices, Patients

No Cosmetic Job With Jabs, Warns Drug Regulator CDSCO

IGI's New Drug Candidate 'ISB 2301' To Target Solid Tumors

BioMarin's Drug Show Significant Growth Gains in Children

US Enlists Small Biotech for Experimental Ebola Treatment

Gilead Inks $140M Deal With Korean API Maker Yuhan

Dr Reddy's launches oral semaglutide biosimilar Obeda in India

Incyte, Genesis Expand Molecular AI For Drug Discovery

BMS Expands AI Integration System-Wide with Anthropic Claude

Dr Reddy's launches oral semaglutide biosimilar Obeda in India

Lupin Gets Tentative FDA Approval for Revefenacin Inhalation

BioSyent Gets Health Canada OK for Thyconvi Levothyroxine

Glenmark USA Launches Vancomycin HCl for Injection

Roche Signs Generic Xofluza Deal with Patent Pool for 129 Countri

Abbvie Loses Patent Plea For Hep C Drug

Lupin Gets Tentative FDA Nod For Revefenacin Inhalation Solution

US Jury Finds Takeda Ran Antitrust Scheme to Delay Generic Drug

Glenmark Pharma Introduces Vancomycin Injection In U.S. Market

TrumpRx, US Drug Site, Lists 600 Generics as Trump Targets Prices

Parabilis IPO Follows Regeneron Deal Amid Rising IPO Listings

IGI's New Drug Candidate 'ISB 2301' To Target Solid Tumors

US Enlists Small Biotech for Experimental Ebola Treatment

Incyte, Genesis Expand Molecular AI For Drug Discovery

Syndax Announces Participation In Upcoming Investor Conferences

Monte Rosa Therapeutics to Attend Upcoming Investor Conferences

Cellectis to Hold Annual Shareholders Meeting on June 25, 2026

Biolinerx To Report First Quarter 2026 Results On May 27, 2026

Nanobiotix Announces Launch Of Global Follow-On Offering

Sanyou Bio Launches SAI-DA 1.0, the AI-Drug Accelerator

Gilead Inks $140M Deal With Korean API Maker Yuhan

Curia Completes API Aseptic Suite Upgrade in Valladolid, Spain

BioNxt Advances Semaglutide ODF into Active Pharma Development

Bulk Drugs And Intermediates Exports Grew 3.76% In FY26

Drugmakers Battle Rising Costs, Export Slump

How HRV Pharma Is Redefining Pharma Value Creation

Provectus Reports PV-10 Clears Tumors in Bladder Cancer Survivors

Piramal Pharma, Botanix Partner on Drug Substance Development

Imports Of Bulk Drugs Decline 3.31 Per Cent In FY26

Patent Pause: Link Extensions to Pendency

No Cosmetic Job With Jabs, Warns Drug Regulator CDSCO

FDA Issues Warning Letter Over Chinese Supplier's GLP-1 Import

India Well-Positioned to Push Back Quality Perception Battle

IPC Reports Rising ADRs Linked to Antidepressants in India

CDSCO Targets Violations in GLP-1 Weight Loss Drug Sales

CDSCO Cannot Prosecute Pharma Under D&C Act: Himachal HC

FDA Warns Researchers and Drugmakers for Clinical, GMP Violations

DIWA Urges Maharashtra FDA to Fix Manpower Crunch for Fake Drugs

Lawmaker Publishes Fda's Unreleased Covid Vaccine Deaths Report

Industry Urges Revision of FDA Guidance on Form 483 Responses

India Plans National Registry to Track Devices, Patients

Johns Hopkins Health Plans Awards $60K to Maryland & Virginia Org

Tarsus Taps John Cena For Its Latest Demodex Blepharitis Campaign